Skip to content
Catalyst

Astragalus membranaceusFinding

Astragalus membranaceus increases serum albumin

raisesVery limited evidenceFinding

01 · The sentence it was drawn from

“Astragalus significantly increased serum albumin (9 studies, 522 participants: MD 3.55 g/L, 95% CI 2.33 to 4.78; I² = 65%).”
Quoted verbatim from Astragalus (a traditional Chinese medicine) for treating chronic kidney disease.
This finding among the 10 findings on its endpoint

Astragalus membranaceus

Serum albumin

raises

Effect as reported

3.55mean difference

CI 2.33 to 4.78

Who
n = 522 · People with chronic kidney disease, dialysis and non-dialysis; pooled randomised and quasi-randomised trials of astragalus against placebo, no treatment or conventional interventions
Dose studied
not reported

Very limited evidencePMID 25335553 · 2014

02 · The study

Study
meta-analysis
Participants
522
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

03 · The paper

The Cochrane database of systematic reviews
What else it reported4 findings · 0 compounds · 4 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M704BY7RWM0XQATPEDRZ4WMK